United Therapeutics Corporation (UTHR) Ownership

$355.39

south_east
-$0.94 (-0.26%)
Day's range
$351.05
Day's range
$358.67

United Therapeutics Corporation Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WEALTHFRONT ADVISERS LLC 02/07/2025 18.31 M $18.26 M   2,090,573.52% 41.06%
BLACKROCK FUNDING, INC. /DE 02/07/2025 5.36 M $1.89 B   0.77% 12.01%
VANGUARD GROUP INC 02/11/2025 4.44 M $1.57 B   0.73% 9.96%
AVORO CAPITAL ADVISORS LLC 02/14/2025 2.76 M $973.94 M   -3.45% 6.19%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 2.46 M $869.36 M   -22.30% 5.52%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 2.09 M $737.22 M   -3.06% 4.68%
FMR LLC 02/13/2025 1.47 M $519.17 M   36.54% 3.30%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.14 M $401.18 M   4.05% 2.55%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 975,444 $344.18 M   0.80% 2.19%
LSV ASSET MANAGEMENT 02/13/2025 908,724 $320.63 M   -6.27% 2.04%
ALLIANCEBERNSTEIN L.P. 02/12/2025 709,043 $250.18 M   28.52% 1.59%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 620,566 $218.98 M   -0.08% 1.39%
PACER ADVISORS, INC. 01/22/2025 597,634 $210.87 M   5.46% 1.34%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/12/2025 542,445 $191.40 M   -15.45% 1.22%
FULLER & THALER ASSET MANAGEMENT, INC. 02/14/2025 532,914 $188.03 M   -6.24% 1.19%
JANUS HENDERSON GROUP PLC 02/14/2025 468,996 $165.49 M   1.86% 1.05%
NORGES BANK 02/12/2025 430,122 $151.76 M   100.00% 0.96%
ASSETMARK, INC 02/06/2025 429,160 $151.42 M   2.19% 0.96%
BANK OF NEW YORK MELLON CORP 02/04/2025 399,424 $140.93 M   -0.42% 0.90%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 397,882 $140.39 M   15.49% 0.89%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 02/14/2025 390,093 $137.64 M   13.48% 0.87%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 370,540 $130.74 M   0.16% 0.83%
SWEDBANK AB 01/22/2025 335,505 $118.38 M   -19.14% 0.75%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 331,675 $117.03 M   -7.76% 0.74%
FRANKLIN RESOURCES INC 02/12/2025 329,379 $116.22 M   31.37% 0.74%
INVESCO LTD. 02/13/2025 318,451 $112.36 M   8.32% 0.71%
FIRST TRUST ADVISORS LP 02/13/2025 304,185 $107.33 M   9.78% 0.68%
FRONTIER CAPITAL MANAGEMENT CO LLC 02/14/2025 243,681 $85.98 M   36.02% 0.55%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 232,373 $81.99 M   9.27% 0.52%
EPOCH INVESTMENT PARTNERS, INC. 02/13/2025 226,212 $79.82 M   -5.27% 0.51%
LORD, ABBETT & CO. LLC 02/14/2025 216,651 $76.44 M   7.42% 0.49%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 02/12/2025 209,204 $73.82 M   -1.24% 0.47%
HSBC HOLDINGS PLC 02/14/2025 204,893 $72.36 M   -9.03% 0.46%
THRIVENT FINANCIAL FOR LUTHERANS 02/10/2025 204,299 $72.09 M   1,325.47% 0.46%
VICTORY CAPITAL MANAGEMENT INC 02/06/2025 193,408 $68.24 M   3.53% 0.43%
JPMORGAN CHASE & CO 02/12/2025 192,256 $67.84 M   -0.15% 0.43%
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 01/23/2025 191,925 $67.72 M   -2.09% 0.43%
AUSTRALIANSUPER PTY LTD 01/30/2025 189,780 $66.96 M   577.08% 0.43%
CLARK CAPITAL MANAGEMENT GROUP, INC. 02/14/2025 189,341 $66.81 M   3.87% 0.42%
LEGAL & GENERAL GROUP PLC 02/13/2025 173,759 $61.31 M   -28.44% 0.39%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/12/2025 163,782 $58.57 M   -1.22% 0.37%
PALO ALTO INVESTORS LP 02/14/2025 155,714 $54.94 M   -15.02% 0.35%
TD ASSET MANAGEMENT INC 02/11/2025 150,454 $53.09 M   5.68% 0.34%
DEUTSCHE BANK AG\ 02/14/2025 143,629 $50.68 M   10.91% 0.32%
POLARIS CAPITAL MANAGEMENT, LLC 01/29/2025 131,850 $46.52 M   -7.12% 0.30%
RETIREMENT SYSTEMS OF ALABAMA 01/27/2025 129,611 $45.73 M   0.18% 0.29%
RHUMBLINE ADVISERS 01/30/2025 126,338 $44.58 M   -1.95% 0.28%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 123,317 $43.51 M   26.52% 0.28%
KBC GROUP NV 01/22/2025 123,055 $43.42 M   6.19% 0.28%
SWISS NATIONAL BANK 02/10/2025 119,455 $42.15 M   -4.48% 0.27%

United Therapeutics Corporation institutional Ownership - FAQ's

During the previous two years, 892 institutional investors and hedge funds held shares of United Therapeutics Corporation. The most heavily invested institutionals were:

Wealthfront Advisers LLC: 18.31 M

BlackRock Funding, Inc. /DE: 5.36 M

VANGUARD GROUP INC: 4.44 M

Avoro Capital Advisors LLC: 2.76 M

WELLINGTON MANAGEMENT GROUP LLP: 2.46 M

RENAISSANCE TECHNOLOGIES LLC: 2.09 M

139.77% of United Therapeutics Corporation stock is owned by institutional investors.

Institutional investors have bought a total of 74.85 M shares in the last 24 months. This purchase volume represents approximately $26.60 B in transactions.